Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
Settings
Settings
Dynamic quotes 
OFFON

4-Traders Homepage  >  Equities  >  OTC Bulletin Board - Other OTC  >  Angiogenex Inc    AGGX

ANGIOGENEX INC (AGGX)
Mes dernières consult.
Most popular
Report
 SummaryQuotesChartsNewsCompany 
Quotes 5-day view   Delayed Quote. Delayed Otc Bulletin Board - Othe…
08/02/2017 08/23/2017 09/12/2017 09/21/2017 10/03/2017 Date
0.51(c) 0.31(c) 0.16(c) 0.16(c) 0.25(c) Last
1 000 3 999 33 280 413 2 000 Volume
+45.71% -39.22% -48.39% 0.00% +56.25% Change
More quotes
Company
AngioGenex, Inc. is a biopharmaceutical company, which focuses on creating products for the treatment, diagnosis and prognosis of cancer.The company was founded by Michael M. Strage on March 31, 1999 and is headquartered in New York, NY. 
Sector
Biotechnology & Medical Research
Calendar

- No events available -

More about the company
Latest news on ANGIOGENEX INC
04/11 ANGIOGENEX, INC. : Financial Statements and Exhibits (form 8-K)
2008 ANGIOGENEX INC COM USD0.001 : AngioGenex Reviews 2008 Achievements and Sets Goal..
2008 ANGIOGENEX INC COM USD0.001 : AngioGenex Appoints New CEO to Direct Development ..
More news
Sector news : Biotechnology & Medical Research - NEC
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval -- Update
10/18DJGILEAD SCIENCES : Cell-Therapy Drug Yescarta Gets FDA Approval
10/18DJACTELION : J&J Net Income Falls After Actelion Deal -- WSJ
10/17 Regeneron-Sanofi drug succeeds mid-stage study
10/17DJJOHNSON & JOHNSON : Outlook Buoyed by Drug Unit -- Update
More sector news : Biotechnology & Medical Research - NEC
Chart ANGIOGENEX INC
Duration : Period :
Angiogenex Inc Technical Analysis Chart | AGGX | US03475U3014 | 4-Traders
Managers
NameTitle
Robert Benezra President, Chief Executive Officer & Director
Michael M. Strage Chairman, Chief Operating Officer & VP
Martin F. Murray Director & Chief Financial Officer
Sector and Competitors
1st jan.Capitalization (M$)
ANGIOGENEX INC4.17%0
INCYTE CORPORATION13.96%24 054
QUINTILES IMS HOLDINGS INC33.89%22 162
LONZA GROUP59.15%19 392
CELLTRION, INC.--.--%19 297
ALNYLAM PHARMACEUTICALS, INC.208.84%10 522